Trial intelligence / Profile preview

Valproic Acid in Ambulant Adults With SMA

NCT00481013Phase 2Completed

Sponsor
University of Utah
Start
Jul 2007
Primary completion
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of valproic acid in spinal muscular atrophy (SMA), sponsored by University of Utah. Started Jul 2007; status: completed.

02

Drugs

valproic acid
03

Conditions

spinal muscular atrophy (SMA)

Beyond the preview

Go deeper on NCT00481013.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00481013.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call